H.R.810 - Stem Cell Research Enhancement Act of 2005109th Congress (2005-2006)
|Sponsor:||Rep. Castle, Michael N. [R-DE-At Large] (Introduced 02/15/2005)|
|Committees:||House - Energy and Commerce|
|Latest Action:||House - 07/19/2006 On motion to refer the bill and the accompanying veto message to the Committee on Energy and Commerce. Agreed to without objection. (All Actions)|
|Roll Call Votes:||There have been 3 roll call votes|
This bill has the status Failed to pass over veto
Here are the steps for Status of Legislation:
- Passed House
- Passed Senate
- To President
- Vetoed by President
- Failed to pass over veto
Text: H.R.810 — 109th Congress (2005-2006)All Information (Except Text)
Text available as:
- PDF (PDF provides a complete and accurate display of this text.) Tip?
[Congressional Bills 109th Congress] [From the U.S. Government Publishing Office] [H.R. 810 Enrolled Bill (ENR)] H.R.810 One Hundred Ninth Congress of the United States of America AT THE SECOND SESSION Begun and held at the City of Washington on Tuesday, the third day of January, two thousand and six An Act To amend the Public Health Service Act to provide for human embryonic stem cell research. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Stem Cell Research Enhancement Act of 2005''. SEC. 2. HUMAN EMBRYONIC STEM CELL RESEARCH. Part H of title IV of the Public Health Service Act (42 U.S.C. 289 et seq.) is amended by inserting after section 498C the following: ``SEC. 498D. HUMAN EMBRYONIC STEM CELL RESEARCH. ``(a) In General.--Notwithstanding any other provision of law (including any regulation or guidance), the Secretary shall conduct and support research that utilizes human embryonic stem cells in accordance with this section (regardless of the date on which the stem cells were derived from a human embryo). ``(b) Ethical Requirements.--Human embryonic stem cells shall be eligible for use in any research conducted or supported by the Secretary if the cells meet each of the following: ``(1) The stem cells were derived from human embryos that have been donated from in vitro fertilization clinics, were created for the purposes of fertility treatment, and were in excess of the clinical need of the individuals seeking such treatment. ``(2) Prior to the consideration of embryo donation and through consultation with the individuals seeking fertility treatment, it was determined that the embryos would never be implanted in a woman and would otherwise be discarded. ``(3) The individuals seeking fertility treatment donated the embryos with written informed consent and without receiving any financial or other inducements to make the donation. ``(c) Guidelines.--Not later than 60 days after the date of the enactment of this section, the Secretary, in consultation with the Director of NIH, shall issue final guidelines to carry out this section. ``(d) Reporting Requirements.--The Secretary shall annually prepare and submit to the appropriate committees of the Congress a report describing the activities carried out under this section during the preceding fiscal year, and including a description of whether and to what extent research under subsection (a) has been conducted in accordance with this section.''. Speaker of the House of Representatives. Vice President of the United States and President of the Senate.